Trial intelligence / Profile preview

Gatifloxacin in pulmonary tuberculosis

NCT00216385Phase 3Unknown

Sponsor
Institut de Recherche pour le Développement
Start
Jan 2005
Countries
5
01

Overview

A Phase 3 trial of gatifloxacin in Tuberculosis (TB), sponsored by Institut de Recherche pour le Développement. Status: unknown.

02

Drugs

gatifloxacin
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on NCT00216385.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00216385.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call